Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

Human Immunology

Volumn 70, Issue 5, 2009, Pages 325-330

  Mantovani, Alberto ^a,b   Sica, Antonio ^a,c   Allavena, Paola ^a   Garlanda, Cecilia ^a   Locati, Massimo ^a,b  

^a Department of Gastroenterology   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cancer; Cancer related inflammation; Cytokines; Inflammation; Macrophages; Monocytes; Myeloid derived suppressor cells; Polarization

Indexed keywords

ANTINEOPLASTIC AGENT;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIODIVERSITY; BONE MARROW; BREAST CANCER; CELL ACTIVATION; CELL FUNCTION; HUMAN; MACROPHAGE ACTIVATION; METASTASIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; SUPPRESSOR CELL; TISSUE INJURY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

ANIMALS; CYTOKINES; HUMANS; IMMUNITY, ACTIVE; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 65049084189     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.02.008     Document Type: Article

References (86)

1. Mantovani A., Allavena P., Sica A., and Balkwill F. Cancer-related inflammation. Nature 454 (2008) 436-444
2. Balkwill F., Charles K.A., and Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 (2005) 211-217
3. Balkwill F., and Mantovani A. Inflammation and cancer: Back to Virchow?. Lancet 357 (2001) 539-545
4. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
5. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23 (2002) 549-555
6. Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 (2004) 2817-2826
7. Bunt S.K., Yang L., Sinha P., Clements V.K., Leips J., and Ostrand-Rosenberg S. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67 (2007) 10019-10026
8. Nagaraj S., and Gabrilovich D.I. Myeloid-derived suppressor cells. Adv Exp Med Biol 601 (2007) 213-223
9. Mantovani A. Cancer: Inflaming metastasis. Nature 457 (2009) 36-37
10. Sica A., and Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117 (2007) 1155-1166
11. Mantovani A. From phagocyte diversity and activation to probiotics: Back to Metchnikoff. Eur J Immunol 38 (2008) 3269-3273
12. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3 (2003) 23-35
13. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005) 953-964
14. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25 (2004) 677-686
15. Mantovani A., Sica A., and Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 37 (2007) 14-16
16. Goerdt S., and Orfanos C.E. Other functions, other genes: Alternative activation of antigen-presenting cells. Immunity 10 (1999) 137-142
17. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 73 (2003) 209-212
18. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., and Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164 (2000) 6166-6173
19. Martinez F.O., Gordon S., Locati M., and Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J Immunol 177 (2006) 7303-7311
20. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8 (2008) 533-544
21. Xu W., Schlagwein N., Roos A., van den Berg T.K., Daha M.R., and van Kooten C. Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur J Immunol 37 (2007) 1594-1599
22. Ludwiczek S., Aigner E., Theurl I., and Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101 (2003) 4148-4154
23. Savage N.D., de Boer T., Walburg K.V., Joosten S.A., van Meijgaarden K., Geluk A., and Ottenhoff T.H. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol 181 (2008) 2220-2226
24. Tiemessen M.M., Jagger A.L., Evans H.G., van Herwijnen M.J., John S., and Taams L.S. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 104 (2007) 19446-19451
25. De Palma M., Murdoch C., Venneri M.A., Naldini L., and Lewis C.E. Tie2-expressing monocytes: Regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 28 (2007) 519-524
26. Grohmann U., Fallarino F., and Puccetti P. Tolerance, DCs and tryptophan: Much ado about IDO. Trends Immunol 24 (2003) 242-248
27. de Visser K.E., Korets L.V., and Coussens L.M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7 (2005) 411-423
28. de Visser K.E., Eichten A., and Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6 (2006) 24-37
29. Mantovani A. Cancer: Inflammation by remote control. Nature 435 (2005) 752-753
30. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2 (2002) 725-734
31. Moore R.J., Owens D.M., Stamp G., Arnott C., Burke F., East N., et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5 (1999) 828-831
32. Hagemann T., Robinson S.C., Schulz M., Trumper L., Balkwill F.R., and Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25 (2004) 1543-1549
33. Pollard J.W. Tumor-educated macrophages promote tumor progression and metastasis. Nat Rev Cancer 4 (2004) 71-78
34. Giavazzi R., Garofalo A., Bani M.R., Abbate M., Ghezzi P., Boraschi D., et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 50 (1990) 4771-4775
35. Lin E.Y., Nguyen A.V., Russell R.G., and Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193 (2001) 727-740
36. Hiratsuka S., Nakamura K., Iwai S., Murakami M., Itoh T., Kijima H., et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2 (2002) 289-300
37. Browatzki M., Pfeiffer C.A., Schmidt J., and Kranzhofer R. Endothelin-1 induces CD40 but not IL-6 in human monocytes via the proinflammatory transcription factor NF-kappaB. Eur J Med Res 10 (2005) 197-201
38. Spinella F., Rosano L., Di Castro V., Natali P.G., and Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 277 (2002) 27850-27855
39. Leek R.D., and Harris A.L. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7 (2002) 177-189
40. O'Sullivan C., and Lewis C.E. Tumor-associated leucocytes: Friends or foes in breast carcinoma. J Pathol 172 (1994) 229-235
41. Ahmed F., Wyckoff J., Lin E.Y., Wang W., Wang Y., Hennighausen L., et al. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res 62 (2002) 7166-7169
42. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65 (2005) 5278-5283
43. Bronte V., and Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5 (2005) 641-654
44. Mantovani A. Cancer: An infernal triangle. Nature 448 (2007) 547-548
45. Zhu P., Baek S.H., Bourk E.M., Ohgi K.A., Garcia-Bassets I., Sanjo H., et al. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124 (2006) 615-629
46. Luo J.L., Tan W., Ricono J.M., Korchynskyi O., Zhang M., Gonias S.L., et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446 (2007) 690-694
47. Wyckoff J.B., Wang Y., Lin E.Y., Li J.F., Goswami S., Stanley E.R., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67 (2007) 2649-2656
48. Mantovani A., Schioppa T., Porta C., Allavena P., and Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25 (2006) 315-322
49. Yang L., Huang J., Ren X., Gorska A.E., Chytil A., Aakre M., et al. Abrogation of TGFbeta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13 (2008) 23-35
50. Lin E.Y., Gouon-Evans V., Nguyen A.V., and Pollard J.W. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7 (2002) 147-162
51. Ishikawa S., Egami H., Kurizaki T., Akagi J., Tamori Y., Yoshida N., et al. Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis. J Exp Clin Cancer Res 22 (2003) 299-306
52. Hildenbrand R., Dilger I., Horlin A., and Stutte H.J. Urokinase and macrophages in tumor angiogenesis. Br J Cancer 72 (1995) 818-823
53. Kim S., Takahashi H., Lin W.-W., Descargues P., Grivennikov S., Kim Y., et al. Carcinoma produced factors activate myeloid cells via TLR2 to stimulate metastasis. Nature 457 (2009) 102-106
54. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
55. Sangaletti S., Di Carlo E., Gariboldi S., Miotti S., Cappetti B., Parenza M., et al. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res 68 (2008) 9050-9059
56. Forssell J., Oberg A., Henriksson M.L., Stenling R., Jung A., and Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 3 (2007) 1472-1479
57. Ohno S., Inagawa H., Dhar D.K., Fujii T., Ueda S., Tachibana M., et al. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 23 (2003) 5015-5022
58. Boonman Z.F., Schurmans L.R., van Rooijen N., Melief C.J., Toes R.E., and Jager M.J. Macrophages are vital in spontaneous intraocular tumor eradication. Invest Ophthalmol Vis Sci 47 (2006) 2959-2965
59. Houghton A.M., Grisolano J.L., Baumann M.L., Kobayashi D.K., Hautamaki R.D., Nehring L.C., et al. Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res 66 (2006) 6149-6155
60. Kaduka Y., Takeda K., Nakayama M., Kinoshita K., Yagita H., and Okumura K. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage. Biochem Biophys Res Commun 331 (2005) 384-390
61. Mantovani A., Bottazzi B., Colotta F., Sozzani S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 13 (1992) 265-270
62. Mantovani A., Caprioli V., Gritti P., and Spreafico F. Human mature macrophages mediate antibody-dependent cellular cytotoxicity on tumor cells. Transplantation 24 (1977) 291-293
63. Mantovani A. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines. Lab Invest 71 (1994) 5-16
64. Taskinen M., Karjalainen-Lindsberg M.L., Nyman H., Eerola L.M., and Leppa S. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone. Clin Cancer Res 13 (2007) 5784-5789
65. Hagemann T., Lawrence T., McNeish I., Charles K.A., Kulbe H., Thompson R.G., et al. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med 205 (2008) 1261-1268
66. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13 (2007) 1050-1059
67. Bronte V., Serafini P., Apolloni E., and Zanovello P. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother 24 (2001) 431-446
68. Nagaraj S., and Gabrilovich D.I. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res 68 (2008) 2561-2563
69. Sinha P., Clements V.K., Bunt S.K., Albelda S.M., and Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179 (2007) 977-983
70. Sinha P., Clements V.K., Fulton A.M., and Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 67 (2007) 4507-4513
71. Kusmartsev S., and Gabrilovich D.I. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol 174 (2005) 4880-4891
72. Otsuji M., Kimura Y., Aoe T., Okamoto Y., and Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci U S A 93 (1996) 13119-13124
73. Yang L., DeBusk L.M., Fukuda K., Fingleton B., Green-Jarvis B., Shyr Y., et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6 (2004) 409-421
74. Gallina G., Dolcetti L., Serafini P., De Santo C., Marigo I., Colombo M.P., et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 116 (2006) 2777-2790
75. Sinha P., Clements V.K., and Ostrand-Rosenberg S. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res 65 (2005) 11743-11751
76. Bronte V., Serafini P., Mazzoni A., Segal D.M., and Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 24 (2003) 302-306
77. Kusmartsev S., Nagaraj S., and Gabrilovich D.I. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J Immunol 175 (2005) 4583-4592
78. Kusmartsev S., Nefedova Y., Yoder D., and Gabrilovich D.I. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 172 (2004) 989-999
79. Huang B., Pan P.Y., Li Q., Sato A.I., Levy D.E., Bromberg J., et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66 (2006) 1123-1131
80. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
81. Allavena P., Sica A., Garlanda C., and Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222 (2008) 155-161
82. Shabo I., Stal O., Olsson H., Dore S., and Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 123 (2008) 780-786
83. Tamimi R.M., Brugge J.S., Freedman M.L., Miron A., Iglehart J.D., Colditz G.A., and Hankinson S.E. Circulating colony stimulating factor-1 and breast cancer risk. Cancer Res 68 (2008) 18-21
84. Byers R.J., Sakhinia E., Joseph P., Glennie C., Hoyland J.A., Menasce L.P., et al. Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 111 (2008) 4764-4770
85. Liu R., Wang X., Chen G.Y., Dalerba P., Gurney A., Hoey T., et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356 (2007) 217-226
86. Seike M., Yanaihara N., Bowman E.D., Zanetti K.A., Budhu A., Kumamoto K., et al. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst 99 (2007) 1257-1269